IN2013MU01985A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU01985A IN2013MU01985A IN1985MU2013A IN2013MU01985A IN 2013MU01985 A IN2013MU01985 A IN 2013MU01985A IN 1985MU2013 A IN1985MU2013 A IN 1985MU2013A IN 2013MU01985 A IN2013MU01985 A IN 2013MU01985A
- Authority
- IN
- India
- Prior art keywords
- empagliflozin
- amorphous form
- preparation
- provides
- abstarct
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1985MU2013 IN2013MU01985A (el) | 2013-06-10 | 2013-06-10 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1985MU2013 IN2013MU01985A (el) | 2013-06-10 | 2013-06-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU01985A true IN2013MU01985A (el) | 2015-05-29 |
Family
ID=54396291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1985MU2013 IN2013MU01985A (el) | 2013-06-10 | 2013-06-10 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2013MU01985A (el) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016169534A1 (en) * | 2015-04-24 | 2016-10-27 | Zentiva, K. S. | Solid forms of amorphous empagliflozin |
CN106317035A (zh) * | 2015-06-23 | 2017-01-11 | 中美华世通生物医药科技(武汉)有限公司 | 恩格列净单晶及其制备方法和用途 |
WO2017203457A1 (en) * | 2016-05-26 | 2017-11-30 | Dr. Reddy's Laboratories Limited | Solid state forms of empagliflozin |
US9902751B2 (en) | 2013-12-30 | 2018-02-27 | Mylan Laboratories Limited | Process for the preparation of empagliflozin |
US10428053B2 (en) | 2015-09-15 | 2019-10-01 | Laurus Labs Limited | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
WO2021123165A1 (en) | 2019-12-19 | 2021-06-24 | Krka, D.D., Novo Mesto | Dosage form comprising amorphous solid solution of empagliflozin with polymer |
-
2013
- 2013-06-10 IN IN1985MU2013 patent/IN2013MU01985A/en unknown
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9902751B2 (en) | 2013-12-30 | 2018-02-27 | Mylan Laboratories Limited | Process for the preparation of empagliflozin |
WO2016169534A1 (en) * | 2015-04-24 | 2016-10-27 | Zentiva, K. S. | Solid forms of amorphous empagliflozin |
CN106317035A (zh) * | 2015-06-23 | 2017-01-11 | 中美华世通生物医药科技(武汉)有限公司 | 恩格列净单晶及其制备方法和用途 |
US10428053B2 (en) | 2015-09-15 | 2019-10-01 | Laurus Labs Limited | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
US10738038B2 (en) | 2015-09-15 | 2020-08-11 | Laurus Labs Limited | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
US10836753B2 (en) | 2015-09-15 | 2020-11-17 | Laurus Labs Limited | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
US11040961B2 (en) | 2015-09-15 | 2021-06-22 | Laurus Labs Limited | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
WO2017203457A1 (en) * | 2016-05-26 | 2017-11-30 | Dr. Reddy's Laboratories Limited | Solid state forms of empagliflozin |
WO2021123165A1 (en) | 2019-12-19 | 2021-06-24 | Krka, D.D., Novo Mesto | Dosage form comprising amorphous solid solution of empagliflozin with polymer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016013689A (es) | Compuestos 4-amino-imidazoquinolina. | |
PH12016500486A1 (en) | Aza-pyridone compounds and uses thereof | |
MA39749A (fr) | Dérivés de pipéridine-dione | |
GEP20186933B (en) | Substituted dihydroisoquinoline compounds | |
PH12015501588B1 (en) | Compounds and methods for treating bacterial infections | |
TW201144301A (en) | Processes for preparing linezolid | |
IN2013MU00711A (el) | ||
IN2013MU01985A (el) | ||
MX2018005785A (es) | Conjugados de anticuerpo anti-cd22-maytansina y metodos de uso de los mismos. | |
NZ730816A (en) | Quinoline carboxamides for use in the treatment of multiple myeloma | |
IN2013MU03862A (el) | ||
NZ732704A (en) | Quinoline carboxamides for use in the treatment of leukemia | |
GEP20186879B (en) | Cycloalkyl-linked diheterocycle derivatives | |
IN2013MU01111A (el) | ||
MX2015013048A (es) | Forma cristalina de un compuesto ansiolitico. | |
IN2013MU03422A (el) | ||
IN2014MU00859A (el) | ||
IN2013MU03308A (el) | ||
IN2013MU03565A (el) | ||
IN2013MU01226A (el) | ||
MX2016013428A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
MX2016002186A (es) | Proceso para preparar dronedarona y sales de la misma. | |
IN2014KN02584A (el) | ||
IN2013MU01160A (el) | ||
IN2013MU02010A (el) |